Avita Medical (ASX: AVH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Avita Medical Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Avita Medical (ASX: AVH)
Latest News
Share Gainers
Why Avita Medical, Imugene, Pantoro, and Tietto shares are pushing higher
Healthcare Shares
Why is the Avita Medical share price rocketing 24% today?
Share Fallers
Why Avita Medical, Delta Lithium, Santos, and Western Africa Resources are dropping
Healthcare Shares
Why did the Avita Medical share price just crash 25%?
Investing Strategies
How I'd try to turn $50k in savings into $1 million worth of ASX shares
Healthcare Shares
3 ASX healthcare stocks that have more than doubled in a year
Opinions
$50k in savings? Here's how I'd try to turn that into ASX passive income of $2k a month!
Healthcare Shares
Guess which ASX healthcare share is rocketing 20% on an FDA approval
Small Cap Shares
Broker says these exciting small cap ASX shares have massive upside
Healthcare Shares
Here's why the Avita Medical share price is tumbling 20% today
Share Gainers
5 top ASX shares that would have more than doubled your money in 2023
52-Week Highs
7 ASX All Ordinaries shares smashing new 52-week highs today
Frequently Asked Questions
-
No, AVITA Medical does not pay dividends at this time.
-
AVITA Medical Inc listed on the ASX on 24 June 2020.
-
Yes, as well as being listed on the ASX, AVITA Medical Inc is listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.
AVH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Avita Medical
AVITA Medical Inc (ASX: AVH) is a healthcare company specialising in regenerative medicine. It is best known for its RECELL system, a burn treatment device that creates 'spray-on skin' from a patient's own skin cells within 30 minutes, avoiding or reducing the need for skin grafts.
The product was originally invented and patented by Western Australian doctor and clinical professor Fiona Wood in 1993.
RECELL is approved for use in Australia, Europe, Canada, China, the Middle East, and Africa. It is also approved for treating adult patients in the US. As well as burns, AVITA Medical has evidence of RECELL's effectiveness for additional skin applications, such as treating chronic and traumatic wounds, scar revision, and vitiligo.
AVITA Medical Inc is domiciled and also listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.